Clinical Trial 43815

Tulsa, OK 74136


Summary:

This study is evaluating the safety and effectiveness of Ozanimod for possible induction treatment for patients with moderate to severe Crohn's disease. 


Qualified Participants Must:

• Ages 18 to 75 years old
• Have been experiencing signs and symptoms of Crohn's disease for at least 3 months
• Have symptoms associated with moderate to severaly active Crohn's disease confirmed by endoscopy


Qualified Participants May Receive:

Close care and monitoring of your CD and general health from the medical professionals on the study team 

Investigational drug (Ozanimod) or placebo

Possible reimbursement for time and travel 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.